Concerto Biosciences
Tap into the microbial world
United States · $23.3M raised
- Employees
- 11–50
- Business Model
- B2B
- Website
- concertobio.com
- Total Funding
- $23.3M
- Last Round
- $300K GrantNov 2022
- Rounds
- 2
About
Microbial ecology company building the largest microbial interaction dataset to develop consumer health and environmental products.
Summary
Concerto Biosciences is a Biotech company based in United States. It has raised $23.3M in total across 2 rounds, most recently a $300K Grant round in Nov 2022. Investors include HHS, Safar Partners and Horizons Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...